Publication: Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand
Issued Date
2004-09-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-20844433383
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.35, No.3 (2004), 566-569
Suggested Citation
S. Vijaykadga, C. Rojanawatsirivej, K. Congpoung, P. Wilairatana, W. Satimai, C. Uaekowitchai, B. Pumborplub, S. Sittimongkol, A. Pinyorattanachote, P. Prigchoo Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.35, No.3 (2004), 566-569. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21567
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand
Other Contributor(s)
Abstract
Chloroquine-resistant Plasmodium vivax has been reported in some Asian countries. In 2003, 161 patients infected with vivax malaria were treated according to the Thai National Drug Policy, with oral chloroquine (approximately 25 mg base/kg body weight, administered over 3 days) followed by primaquine on day 28 (15 mg daily for 14 days). All the patients were initially cured after chloroquine treatment, clearing their parasitemias within 7 days. Only one patient presented with parasitemia at 28 days. These data indicate that chloroquine is still effective for the treatment of patients with vivax malaria in Thailand.